TITLE

The P450 system and CV outcomes with clopidogrel

AUTHOR(S)
Kuritzky, Louis
PUB. DATE
December 2010
SOURCE
Internal Medicine Alert;12/15/2010 Supplement, p183
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the impact of the P450 system and clopidogrel on the reduction of cardio-vascular events (CV) among people with atrial fibrillation.
ACCESSION #
57803288

 

Related Articles

  • The P450 system and CV outcomes with clopidogrel.  // Primary Care Reports;Jan2011 Clinical Briefs in Primary, Vol. 16 Issue 1, p1 

    The article discusses a research study conducted on subjects with atrial fibrillation or post-acute coronary syndrome (ACS) who were exposed to clopidogrel and received CYP2C19, concluding that the P450 system and clopidogrel do not ensure positive effects on cardiovascular outcomes or bleeding...

  • New anticoagulant option 'could replace warfarin'. Tanday, Sanjay // GP: General Practitioner;9/4/2009, p7 

    The article presents a research by Dr. Sarah Jarvis and colleagues, which states that dabigatran, an alternative for Clopidogrel, has been found that reduced bleeding. Researchers gave 18,113 atrial fibrillation (AF) patients either dabigatran 110mg or 150mg twice daily, or an adjusted dose of...

  • Effect of clopidogrel added to aspirin in patients with atrial fibrillation.  // Australian Journal of Pharmacy;Oct2009, Vol. 90 Issue 1073, p68 

    The article discusses the effects of clopidogrel when added to aspirin which are given to patients with atrial fibrillation. It notes that a study was made to investigate the hypothesis that adding clopidogrel to aspirin will reduce the risk of vascular events in patients with atrial...

  • The P450 system and CV outcomes with clopidogrel.  // Internal Medicine Alert;12/15/2010, Vol. 32 Issue 23, p183 

    The article reports on the findings of a study concerning the use of CYP2C19 genotyping to determine the efficacy of clopidogrel treatment for persons with atrial fibrillation in the U.S.

  • Clopidogrel unaffected by CYP2C19 loss-of-function alleles in patients with ACS, AF.  // Cardiology Today;Dec2010, Vol. 13 Issue 12, p34 

    The article reports that the effect of clopidogrel compared with placebo has remained consistent regardless of CYP2C19 loss-of-function allele status for patients with acute coronary syndromes or atrial fibrillation, according to data from the Clopidogrel in Unstable Angina to Prevent Recurrent...

  • National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Brieger, David; Amerena, John; Attia, John R.; Bajorek, Beata; Chan, Kim H.; Connell, Cia; Freedman, Ben; Ferguson, Caleb; Hall, Tanya; Haqqani, Haris M.; Hendriks, Jeroen; Hespe, Charlotte M.; Hung, Joseph; Kalman, Jonathan M.; Sanders, Prashanthan; Worthington, John; Yan, Tristan; Zwar, Nicholas A. // Medical Journal of Australia;10/15/2018, Vol. 209 Issue 8, p356 

    Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are continually evolving and care for patients requires confidence in integrating these new...

  • Flecainide.  // Reactions Weekly;12/2/2016, Vol. 1630 Issue 1, p110 

    An abstract of the article "Use of anti arrhythmic drugs (AAD) in management of patients with atrial fibrillation (AF), single center experience" by M.A. Ahmed and others is presented.

  • Clopidogrel + aspirin in atrial fibrillation. Kuritzky, Louis // Primary Care Reports;Aug2009 Supplement, p15 

    The article discusses research on the impact of clopidogrel and aspirin in patients suffering from atrial fibrillation (FIB). It references the study "The ACTIVE Investigators: Effect of Clopidogrel Added to Aspirin in Patients With Atrial Fibrillation" published in a 2009 issue of the "New...

  • Fatigue in a Patient with Atrial Fibrillation. Germano, Joseph J.; Steingart, Richard M. // Cortlandt Forum;8/25/2002, Vol. 15 Issue 8, p68 

    Describes a case of fatigue in a patient with atrial fibrillation. Reason for administration of amiodarone; Multiorgan side effects of amiodarone; Characteristics and physiologic effects of amiodarone.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics